Cargando…
High expression of AGBL2 is a novel prognostic factor of adverse outcome in patients with ovarian carcinoma
The putative oncogenic role of ATP/GTP binding protein like 2 (AGBL2) in catalyzing α-tubulin detyrosination has recently been characterized in cancer. However, the status of AGBL2 expression in ovarian cancer and its potential clinical and prognostic significance remain unclear. In the present stud...
Autores principales: | He, Wei-Peng, Wang, Li-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781648/ https://www.ncbi.nlm.nih.gov/pubmed/31612000 http://dx.doi.org/10.3892/ol.2019.10829 |
Ejemplares similares
-
Expression of RARRES1 and AGBL2 and progression of conventional renal cell carcinoma
por: Peterfi, Lehel, et al.
Publicado: (2020) -
Clinical implications of AGBL2 expression and its inhibitor latexin in breast cancer
por: Zhang, Hao, et al.
Publicado: (2014) -
High expression of HILPDA is an adverse prognostic prognostic factor in hepatocellular carcinoma
por: Wang, Xiao, et al.
Publicado: (2023) -
Systematic review of SLC4A11, ZEB1, LOXHD1, and AGBL1 variants in the development of Fuchs’ endothelial corneal dystrophy
por: Tsedilina, Tatiana Romanovna, et al.
Publicado: (2023) -
Outcome and prognostic factors of unexpected ovarian carcinomas
por: Cheng, Ching‐Yu, et al.
Publicado: (2022)